Loading stock data…
SL Science Holding Limited (SLBT)
$2.61-0.01 (-0.38%)
Market ClosedLast close Sep 9
SL Science Holding Limited manufactures cosmetic skin care and scalp care products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SL Science Holding Limited in the Healthcare sector is trading at $2.61 with a market capitalization of $1.5B. The stock is currently near its 52-week low of $2.51, remaining 66.5% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Total Revenue | — | — | — |
| Gross Profit | — | — | — |
| Operating Income | — | — | — |
| Net Income | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.50B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
54,123
Recent News
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall
SL Science Holding has experienced a steep share price decline so far this year, while current valuation checks suggest the stock does not screen as a clear bargain. Year to date the share price is down 73.9%, which indicates that sentiment around SL Science Holding has weakened sharply. Future revenue and cash flow expectations can still support the share price if the business executes well. However, any setback in funding or clinical and product development may weigh heavily on what...
Sector Update: Healthcare Stocks Decline Late Afternoon
Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.7% a
Top Midday Decliners
SL Science (SLBT) reported a 2025 net loss late Thursday that was wider than a year earlier amid a d